The detection of increased numbers of E6-specific CD8+ CTLs in the periphery after E6-RHDV-VLP-PADRE vaccination correlated with reduced tumour size and lengthened survival time indicating a likely infiltration of E6 specific CD8+ T cells into the tumour, as has been reported by others to be necessary for tumour regression [46]. Here, CD8A is linked to neoplasm.